Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The Future Of Photochemistry

Published: Wednesday, February 26, 2014
Last Updated: Wednesday, February 26, 2014
Bookmark and Share
The Vapourtec UV-150 offers potential routes for novel compounds and building blocks together with possible new manufacturing processes.

Two years in development, the plug and play reactor offers a wide range of features that makes it an industry first. With no intensive set up required, it is unique within the field of flow chemistry and is designed to complement Vapourtec’s existing R-Series and E-Series flow chemistry systems used in hundreds of laboratories around the world.

The UV-150 allows for safe access to photo chemistry processes that hasn’t existed before due to the unique design of the 150 Watt lamp, filters and reactors that deliver enhanced power, analytics and temperature control. The reactor, around 10% of the volume of other reactors that offer similar throughput, operates between -5° and 80°C.

Dr Duncan Browne, an experienced post-doc and flow chemist involved in research using the UV-150 at the Ley Group, Cambridge commented: “The benefits accrued from the combination of photochemistry and flow methods were demonstrated in the first report from Booker-Milburn and Berry*. However, the modularity, convenience and compact scale of the Vapourtec system sets-up the opportunity for a great deal more chemists to explore the area of photochemically induced reactions leading to interesting and functionalisable building blocks. Ready access to such important techniques can only ever benefit synthesis chemistry.” 

According to Vapourtec Managing Director Duncan Guthrie, the new reactor could have a dramatic impact on the potential of photochemistry within continuous flow processing: “The UV-150 is a truly unique innovation that gives chemists the opportunity to develop ‘reagent less’ and scalable manufacturing of new and existing compounds and is a far more efficient alternative to traditional batch chemistry approaches.

“Current green photochemistry processes can be hazardous due to the lack of control and scalability inherent within traditional batch systems. The plug and play nature of the continuous processing UV-150 makes it easy to use with a small dedicated power supply and a patented cooling system delivering additional advantages.

“There is real physics behind the UV-150 with a compact high intensity 150 watt lamp, temperature control, wavelength filtering and reflective surfaces all designed to ensure that the photons emitted by the lamp are efficiently absorbed by the reagents. Provision has even been made for mounting an optional spectrometer, this feature allows the absorption by the reagents to be monitored in real time which is yet another unique feature.  

“Artemisinin, currently the most effective treatment against malaria, is a perfect example of what can be achieved using photochemistry within a continuous flow synthesis.

“In late 2011 Professor Dr Seeberger and Dr Levesque of the Max Planck Institute reported on a continuous flow conversion of dihydroartemisinic acid, extracted from sweet wormwood (Artemisia annua), into artemisinin with a continuous photochemical transformation central to the reaction.

“There is currently nothing as efficient and easy-to-use as this reactor available in the field of flow chemistry and we are convinced that it will play a pivotal role in many chemical and pharmaceutical breakthroughs in the future. 

“Despite still being an underutilised technique, there is growing interest in photochemistry and this is a perfect fit for industry requirements. This is the biggest innovation we have developed so far and there is genuine interest and application within many fields including academic research, pharma, environmental and industrial chemistry,” added Duncan. 

Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors across the globe including education, pharmaceutical and industry and their technology has been cited as playing a pivotal part in recent major research breakthroughs.

Established in 2003, Vapourtec has developed a flourishing international market for its technology with sales across much of the developed world including USA, China, Japan, Singapore and India.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Vapourtec Ties in with Singapore Distributor
The company has reinforced its presence in Asia by signing a distribution agreement with Singapore-based Gaia Science.
Tuesday, July 07, 2015
Vapourtec Launches Chinese Collaboration
Research collaboration to develop novel, continuous flow, photochemical reactions using Vapourtec's easy-Photochem reactor system.
Tuesday, May 19, 2015
Continuous Flow of Breakthroughs for Vapourtec
Flow chemistry systems designed and manufactured by Vapourtec have recently reached the milestone of having been cited in 150 peer review publications.
Thursday, December 11, 2014
Vapourtec Expands R-Series Capabilities
UK-based flow chemistry engineering specialists Vapourtec has extended the capabilities of its R-Series system with a new addition to its range of pump modules.
Wednesday, November 19, 2014
Photochemistry Potential Revealed in Application Notes
Four application notes from Vapourtec now available to download in full from the Company’s website.
Thursday, October 09, 2014
Vapourtec Sees Flow Chemistry Growth in India
A distribution partnership with Mumbai-based Pi-Process Intensification has enabled Vapourtec to establish a burgeoning market for its flow chemistry systems.
Tuesday, September 09, 2014
Green Chemistry Hits Full Flow with China UK Partnership
Vapourtec signs agreement with Nanjing University of Technology (NJUT) in China to establish a joint operation in the fast growing, hi tec field of flow chemistry.
Tuesday, December 17, 2013
Vapourtec Reach Twin Milestones
Vapourtec is celebrating has reached the twin milestones of 10 years in business and being featured in 100 peer reviewed publications.
Monday, October 14, 2013
Vapourtec Publishes Flow Chemistry Guide
Vapourtec partners with Dr Nicholas Leadbeater and the New Synthetic Methods Group.
Thursday, September 26, 2013
Vapourtec Pump Key to Organometallic Process
Paper describes a telescoped continuous flow process that produces breast cancer drug Tamoxifen at the rate of one dose every 5 seconds.
Wednesday, September 11, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!